Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Naveen Pemmaraju: Pacritinib Versus Momelotinib in Thrombocytopenic Myelofibrosis
Photo: faculty.mdanderson.org
Jun 27, 2026, 13:40

Naveen Pemmaraju: Pacritinib Versus Momelotinib in Thrombocytopenic Myelofibrosis

Naveen Pemmaraju, Executive Director-Cancer Medicine for MDACC Cancer Network, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Expert Review of Hematology, adding:

“Pleased to share our brand new collaborative MPN paper just published in Expert Review of Hematology!”

Title: Efficacy of pacritinib versus momelotinib in patients with thrombocytopenic myelofibrosis: a matching-adjusted indirect treatment comparison

Authors: Naveen Pemmaraju, Alessandro Lucchesi, Stephen T Oh, Koo Wilson, Zalmai Hakimi, Sarah A Buckley, Purvi Suthar, Mikolaj Parkitny, Piotr Wojciechowski, Klaudia Kolonko, John O Mascarenhas

Naveen Pemmaraju: Pacritinib Versus Momelotinib in Thrombocytopenic Myelofibrosis

Stay updated on all scientific advances with Hemostasis Today.

Alessandro Lucchesi Expert Review of Hematology Health Hematology Hemostasis Hemostasis News Hemostasis Today John O Mascarenhas Klaudia Kolonko Koo Wilson Medicine Mikolaj Parkitny Momelotinib MPN Naveen Pemmaraju Pacritinib Piotr Wojciechowski Purvi Suthar Sarah A Buckley Stephen T Oh thrombosis Zalmai Hakimi
NewsFeed